Chang, Y-C <br/><br/>
Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  Nov 2015 
 - 1460-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1464-5491 
<br/><br/><label>Standard No.: </label>10.1111/dme.12800  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Cardiovascular Diseases--complications<br/>Cohort Studies<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Angiopathies--epidemiology<br/>Diabetic Cardiomyopathies--epidemiology<br/>Drug Therapy, Combination<br/>Electronic Health Records<br/>Female<br/>Follow-Up Studies<br/>Glycoside Hydrolase Inhibitors--administration & dosage<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Male<br/>Metformin--administration & dosage<br/>Middle Aged<br/>Myocardial Infarction--complications<br/>National Health Programs<br/>Retrospective Studies<br/>Risk<br/>Taiwan--epidemiology